S. E. Clarke
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
- Cancer Treatment and Pharmacology
Papers in
-
- Pharmacogenetics and Drug Metabolism 8
- Drug-Induced Hepatotoxicity and Protection 2
- Oncology 5
- Drug Transport and Resistance Mechanisms 4
- Co-authors
- R J Chenery (8 shared papers)J. C. Bloomer (6 shared papers)Phil Jeffrey (1 shared paper)Graeme Smith (1 shared paper)Sandra Baldwin (1 shared paper)Andrew W. Harrell (3 shared papers)Joann Sanders–Loehr (1 shared paper)K Rowland‐Yeo (1 shared paper)
- Journals
- Xenobiotica (6 papers)Drug Metabolism and Disposition (3 papers)Applied and Environmental Microbiology (1 paper)British Journal of Clinical Pharmacology (1 paper)Current Drug Metabolism (1 paper)
- Partner nations
- United KingdomUnited States
In The Last Decade
S. E. Clarke
14 papers receiving 895 citations
Peers
Comparison fields: 5 of 97
- Pharmacology 597
- Oncology 317
- Biochemistry 76
- Pharmacology 118
- Pharmaceutical Science 35
Countries citing papers authored by S. E. Clarke
This map shows the geographic impact of S. E. Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. E. Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. E. Clarke more than expected).
Fields of papers citing papers by S. E. Clarke
This network shows the impact of papers produced by S. E. Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. E. Clarke. The network helps show where S. E. Clarke may publish in the future.
Co-authors
The 19 scholars most cited alongside S. E. Clarke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 269 | |
| 2 | 1998 | 104 | |
| 3 | 2006 | 95 | |
| 4 | 2001 | 92 | |
| 5 | 1987 | 76 | |
| 6 | 1995 | 75 | |
| 7 | 1994 | 75 | |
| 8 | 1994 | 66 | |
| 9 | In vitro identification of the P450 enzymes responsible for the metabolism of ropinirole. | 1997 | 33 |
| 10 | 1994 | 24 | |
| 11 | 1996 | 23 | |
| 12 | 1995 | 17 | |
| 13 | 1994 | 10 | |
| 14 | 1994 | 2 |
About S. E. Clarke
S. E. Clarke is a scholar working on Pharmacology, Oncology, Molecular Biology, Epidemiology and Spectroscopy, having authored 14 papers that have together received 961 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (4 papers), Biochemical and Molecular Research (2 papers), Analytical Chemistry and Chromatography (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Hepatitis C virus research (2 papers), Animal Genetics and Reproduction (1 paper) and Aquatic Ecosystems and Phytoplankton Dynamics (1 paper). The work is most often cited by research in Pharmacology (597 citations), Oncology (317 citations), Biochemistry (76 citations), Pharmacology (118 citations) and Pharmaceutical Science (35 citations). S. E. Clarke has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include R J Chenery, J. C. Bloomer, Phil Jeffrey, Graeme Smith, Sandra Baldwin, Andrew W. Harrell, Joann Sanders–Loehr, K Rowland‐Yeo, Amin Rostami‐Hodjegan and Chris Lennard. Their work appears in journals such as Xenobiotica, Drug Metabolism and Disposition, Applied and Environmental Microbiology, British Journal of Clinical Pharmacology and Current Drug Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.